These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15847116)

  • 1. Visual assessment of medial temporal atrophy on MR films in Alzheimer's disease: comparison with volumetry.
    Bresciani L; Rossi R; Testa C; Geroldi C; Galluzzi S; Laakso MP; Beltramello A; Soininen H; Frisoni GB
    Aging Clin Exp Res; 2005 Feb; 17(1):8-13. PubMed ID: 15847116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of automated volumetry of the hippocampus using NeuroQuant® and visual assessment of the medial temporal lobe in Alzheimer's disease.
    Persson K; Barca ML; Cavallin L; Brækhus A; Knapskog AB; Selbæk G; Engedal K
    Acta Radiol; 2018 Aug; 59(8):997-1001. PubMed ID: 29172642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study.
    Wahlund LO; Julin P; Johansson SE; Scheltens P
    J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):630-5. PubMed ID: 11032615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is radiological evaluation as good as computer-based volumetry to assess hippocampal atrophy in Alzheimer's disease?
    Boutet C; Chupin M; Colliot O; Sarazin M; Mutlu G; Drier A; Pellot A; Dormont D; Lehéricy S;
    Neuroradiology; 2012 Dec; 54(12):1321-30. PubMed ID: 22782577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining Visual Rating Scales for Medial Temporal Lobe Atrophy and Posterior Atrophy to Identify Amnestic Mild Cognitive Impairment from Cognitively Normal Older Adults: Evidence Based on Two Cohorts.
    Sheng C; Sun Y; Wang M; Wang X; Liu Y; Pang D; Liu J; Bi X; Du W; Zhao M; Li Y; Li X; Jiang J; Han Y
    J Alzheimers Dis; 2020; 77(1):323-337. PubMed ID: 32716355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment.
    Visser PJ; Verhey FR; Hofman PA; Scheltens P; Jolles J
    J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):491-7. PubMed ID: 11909909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medial temporal lobe atrophy and depressive symptoms in elderly patients with and without Alzheimer disease.
    Enache D; Cavallin L; Lindberg O; Farahmand B; Kramberger MG; Westman E; Jelic V; Eriksdotter M; Ballard C; Winblad B; Wahlund LO; Aarsland D
    J Geriatr Psychiatry Neurol; 2015 Mar; 28(1):40-8. PubMed ID: 25080472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new age-related cutoff of medial temporal atrophy scale on MRI improving the diagnostic accuracy of neurodegeneration due to Alzheimer's disease in a Chinese population.
    Wei M; Shi J; Ni J; Zhang X; Li T; Chen Z; Zhou M; Zhang L; Tan Z; Wang Y; Tian J
    BMC Geriatr; 2019 Feb; 19(1):59. PubMed ID: 30819102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between the accuracy of voxel-based morphometry and hippocampal volumetry in Alzheimer's disease.
    Testa C; Laakso MP; Sabattoli F; Rossi R; Beltramello A; Soininen H; Frisoni GB
    J Magn Reson Imaging; 2004 Mar; 19(3):274-82. PubMed ID: 14994294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: Validation in a large memory clinic population.
    Claus JJ; Staekenborg SS; Holl DC; Roorda JJ; Schuur J; Koster P; Tielkes CEM; Scheltens P
    Eur Radiol; 2017 Aug; 27(8):3147-3155. PubMed ID: 28083697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of automated medial temporal lobe atrophy scale to Alzheimer disease.
    Ridha BH; Barnes J; van de Pol LA; Schott JM; Boyes RG; Siddique MM; Rossor MN; Scheltens P; Fox NC
    Arch Neurol; 2007 Jun; 64(6):849-54. PubMed ID: 17562933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards validation in clinical routine: a comparative analysis of visual MTA ratings versus the automated ratio between inferior lateral ventricle and hippocampal volumes in Alzheimer's disease diagnosis.
    Wittens MMJ; Allemeersch GJ; Sima DM; Vanderhasselt T; Raeymaeckers S; Fransen E; Smeets D; de Mey J; Bjerke M; Engelborghs S
    Neuroradiology; 2024 Apr; 66(4):487-506. PubMed ID: 38240767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal atrophy has limited usefulness as a diagnostic biomarker on the early onset Alzheimer's disease patients: A comparison between visual and quantitative assessment.
    Falgàs N; Sánchez-Valle R; Bargalló N; Balasa M; Fernández-Villullas G; Bosch B; Olives J; Tort-Merino A; Antonell A; Muñoz-García C; León M; Grau O; Castellví M; Coll-Padrós N; Rami L; Redolfi A; Lladó A
    Neuroimage Clin; 2019; 23():101927. PubMed ID: 31491836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment.
    Ferreira D; Cavallin L; Larsson EM; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Simmons A; Wahlund LO; Westman E;
    J Intern Med; 2015 Sep; 278(3):277-90. PubMed ID: 25752192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between visual assessment of MTA and hippocampal volumes in an elderly, non-demented population.
    Cavallin L; Bronge L; Zhang Y; Oksengård AR; Wahlund LO; Fratiglioni L; Axelsson R
    Acta Radiol; 2012 Jun; 53(5):573-9. PubMed ID: 22593123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease.
    Lehmann M; Koedam EL; Barnes J; Bartlett JW; Ryan NS; Pijnenburg YA; Barkhof F; Wattjes MP; Scheltens P; Fox NC
    Neurobiol Aging; 2012 Mar; 33(3):627.e1-627.e12. PubMed ID: 21596458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual assessment of medical temporal lobe atrophy in demented and healthy control subjects: correlation with volumetry.
    Wahlund LO; Julin P; Lindqvist J; Scheltens P
    Psychiatry Res; 1999 Jun; 90(3):193-9. PubMed ID: 10466738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.
    Scheltens P; Leys D; Barkhof F; Huglo D; Weinstein HC; Vermersch P; Kuiper M; Steinling M; Wolters EC; Valk J
    J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):967-72. PubMed ID: 1431963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-modality assessment of medial temporal lobe atrophy in a non-demented population: application of a visual rating scale template across radiologists with varying clinical experience.
    Håkansson C; Tamaddon A; Andersson H; Torisson G; Mårtensson G; Truong M; Annertz M; Londos E; Björkman-Burtscher IM; Hansson O; van Westen D
    Eur Radiol; 2022 Feb; 32(2):1127-1134. PubMed ID: 34328536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs.
    Pereira JB; Cavallin L; Spulber G; Aguilar C; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Aarsland D; Lovestone S; Simmons A; Wahlund LO; Westman E;
    J Intern Med; 2014 Mar; 275(3):317-30. PubMed ID: 24118559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.